TCL Archive CCOP Review Competed, Enough Good Applications In Funding Range To Get Viable Program Started February 18, 1983
TCL Archive FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended July 28, 1989
TCL Archive In Brief: House Cuts NCI Rescission To $7.73 Million; Weinhuse, Ultmann New ACCR, ASCO Presidents May 8, 1981
TCL Archive FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma. February 17, 2006
